포스파티드산

Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy.

1. Int J Nanomedicine. 2025 Nov 25;20:14057-14073. doi: 10.2147/IJN.S544668. eCollection 2025. Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy. Tan J(#)(1)(2)(3), Fang J(#)(1)(2)(4), Luo W(#)(1)(2)(5), Chen X(6), Liang Y(1)(2), Huang Z(1)(

Synergism of in vitro plasmodicidal activity of phospholipase A2 isoforms isolated from panamanian Bothrops asper venom.

2. Chem Biol Interact. 2021 Sep 1;346:109581. doi: 10.1016/j.cbi.2021.109581. Epub 2021 Jul 21. Synergism of in vitro plasmodicidal activity of phospholipase A2 isoforms isolated from panamanian Bothrops asper venom. Simões-Silva R(1), Alfonso JJ(2), Gómez AF(2), Sobrinho JC(3), Kayano AM(4), de

Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex.

3. Cancer Res. 2021 Apr 15;81(8):2086-2100. doi: 10.1158/0008-5472.CAN-20-2218. Epub 2021 Feb 16. Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex. Kovalenko A(1), Sanin A(1), Kosmas K(1), Zhang L(1), Wang J(1), Akl EW(1),

The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.

4. PLoS One. 2013 Aug 23;8(8):e73173. doi: 10.1371/journal.pone.0073173. eCollection 2013. The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease. Liu Y(1), Käch A, Ziegler U, Ong AC, Wallace DP, Arcaro A, Serra AL. Author information: (1)Institute of

Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable.

5. Mol Cell Biol. 2013 Jan;33(1):136-45. doi: 10.1128/MCB.00869-12. Epub 2012 Oct 29. Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable. Sato T(1), Hongu T, Sakamoto M, Funakoshi Y

Phospholipase D participates in H(2)O(2)-induced A549 alveolar epithelial cell migration.

6. Exp Lung Res. 2012 Oct;38(8):427-33. doi: 10.3109/01902148.2012.719282. Phospholipase D participates in H(2)O(2)-induced A549 alveolar epithelial cell migration. Shao ZR(1), Wang Q, Xu XF, Zhang Z, Lu YB, Shen G, Wu M. Author information: (1)Department of Cardiothoracic Surgery, Second Affili

Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.

7. J Neurosci. 2010 Dec 8;30(49):16419-28. doi: 10.1523/JNEUROSCI.3317-10.2010. Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. Oliveira TG(1), Chan RB, Tian H, Laredo M, Shui G, Staniszewski A, Zhang H, Wang L, Kim TW, Duff KE, Wenk

TLR-4 mediated group IVA phospholipase A(2) activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent.

8. Biochim Biophys Acta. 2009 Oct;1791(10):975-82. doi: 10.1016/j.bbalip.2009.02.002. Epub 2009 Feb 20. TLR-4 mediated group IVA phospholipase A(2) activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent. Grkovich A(1), Armando A, Quehenberger O, Dennis EA. Author info

Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells.

9. Neuroscience. 2008 Oct 2;156(2):266-76. doi: 10.1016/j.neuroscience.2008.07.042. Epub 2008 Aug 5. Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells. Brandenburg LO(1), Konrad M, Wruck C, Koch T,

Dioleoyl phosphatidic acid induces morphological changes through an endogenous LPA receptor in C6 glioma cells.

10. Arch Pharm Res. 2008 May;31(5):628-33. doi: 10.1007/s12272-001-1204-7. Epub 2008 May 15. Dioleoyl phosphatidic acid induces morphological changes through an endogenous LPA receptor in C6 glioma cells. Chang YJ(1), Kim YL, Jo JY, Kyeok K, Kim HL, Im DS. Author information: (1)Laboratory of P

Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies.

11. Lipids Health Dis. 2024 May 25;23(1):154. doi: 10.1186/s12944-024-02121-0. Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies. Takanashi Y(1), Kahyo T(2)(3), Sekihara K(4), Kawase A(4), Setou M(2)(3)(5), Funai K(4). Author info

Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review.

12. Rheumatology (Oxford). 2015 Nov;54(11):2042-50. doi: 10.1093/rheumatology/kev226. Epub 2015 Jul 7. Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review. Rodríguez-García V(1), Ioannou Y(2), Fernández-Nebro A(1)